Gene

Glycoconjugate

Biology

Glycoprotein

Cancer research

Computational biology

Glycosylation

Genetics

Physics

Glycan

Bioinformatics

Optics

Precision medicine

Tumor microenvironment

Tumor cells

Crosstalk

Medicine

Disease

Cancer

Phenotype

Pathology

Frontiers in Oncology

Decades of research have disclosed a plethora of alterations in protein glycosylation that decisively impact in all stages of disease and ultimately contribute to more aggressive cell phenotypes. The biosynthesis of cancer-associated glycans and its reflection in the glycoproteome is driven by microenvironmental cues and these events act synergistically towards disease evolution. Such intricate crosstalk provides the molecular foundations for the activation of relevant oncogenic pathways and leads to functional alterations driving invasion and disease dissemination. However, it also provides an important source of relevant glyco(neo)epitopes holding tremendous potential for clinical intervention. Therefore, we highlight the transversal nature of glycans throughout the currently accepted cancer hallmarks, with emphasis on the crosstalk between glycans and the tumor microenvironment stromal components. Focus is also set on the pressing need to include glycans and glycoconjugates in comprehensive panomics models envisaging molecular-based precision medicine capable of improving patient care. We foresee that this may provide the necessary rationale for more comprehensive studies and molecular-based intervention.

Protein Glycosylation and Tumor Microenvironment Alterations Driving Cancer Hallmarks